5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine

• UNSPSC Description:

  5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine (2',3'-Di-O-acetyl-5'-deoxy-5-fluorocytidine) is an antiviral compound that inhibits HBV reverse transcriptase activity. 5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine shows potential to control HBV replication in vitro. 5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine, as a nucleoside analog, may provide a new option for the suppression of chronic hepatitis B[1].

• Target Antigen:

  Endogenous Metabolite

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/5-deoxy-2-3-di-o-acetyl-5-fluorocytidine.html

• Purity:

  98.50

• Smiles:

  C[C@@H]1[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](N2C=C(F)C(N)=NC2=O)O1

• Molecular Weight:

  329.28

• References & Citations:

  [1]Discovering novel direct acting antiviral agents for HBV using in silico screening

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, protect from light)

• Clinical Information:

  No Development Reported

• CAS Number:

  161599-46-8